APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Ceritinib Capsules

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Ceritinib Capsules Market Outlook and Growth Opportunities 2026

Report ID 173976530427 December 2025190 pages

Choose your research edition.

Industry ResearchCeritinib Capsules Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Ceritinib Capsules Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Ceritinib Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ceritinib Capsules Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Ceritinib Capsules Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Ceritinib Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Ceritinib Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ceritinib Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ceritinib Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Ceritinib Capsules market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Ceritinib Capsules market include Novartis and Jiangsu Aosaikang Pharmaceutical among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Ceritinib Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ceritinib Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ceritinib Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ceritinib Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.

Ceritinib Capsules Segment by Company

Novartis

Jiangsu Aosaikang Pharmaceutical

Ceritinib Capsules Segment by Type

150mg

450mg

Ceritinib Capsules Segment by Application

Locally Advanced NSCLC

Metastatic NSCLC

Ceritinib Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Ceritinib Capsules status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Ceritinib Capsules market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Ceritinib Capsules significant trends, drivers, influence factors in global and regions.

6. To analyze Ceritinib Capsules competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ceritinib Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ceritinib Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ceritinib Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ceritinib Capsules market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ceritinib Capsules industry.

Chapter 3: Detailed analysis of Ceritinib Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Ceritinib Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Ceritinib Capsules in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Ceritinib Capsules Industry Trends Table 2. Ceritinib Capsules Industry Drivers Table 3. Ceritinib Capsules Industry Opportunities and Challenges Table 4. Ceritinib Capsules Industry Restraints Table 5. Global Ceritinib Capsules Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Ceritinib Capsules Revenue Share by Company (2021-2026) Table 7. Global Ceritinib Capsules Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Ceritinib Capsules Sales Volume Share by Company (2021-2026) Table 9. Global Ceritinib Capsules Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Ceritinib Capsules Company Ranking, (2024-2026) & (USD Million) Table 11. Global Ceritinib Capsules Key Company Manufacturing Base & Headquarters Table 12. Global Ceritinib Capsules Company, Product Type & Application Table 13. Global Ceritinib Capsules Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Ceritinib Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 150mg Table 18. Significant Companies of 450mg Table 19. Global Ceritinib Capsules Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Ceritinib Capsules Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Ceritinib Capsules Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Ceritinib Capsules Sales Volume Share by Type (2021-2026) Table 23. Global Ceritinib Capsules Sales Volume Share by Type (2027-2032) Table 24. Global Ceritinib Capsules Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Ceritinib Capsules Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Ceritinib Capsules Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Ceritinib Capsules Sales Value Share by Type (2021-2026) Table 28. Global Ceritinib Capsules Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Locally Advanced NSCLC Table 30. Significant Companies of Metastatic NSCLC Table 31. Global Ceritinib Capsules Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Ceritinib Capsules Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Ceritinib Capsules Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Ceritinib Capsules Sales Volume Share by Application (2021-2026) Table 35. Global Ceritinib Capsules Sales Volume Share by Application (2027-2032) Table 36. Global Ceritinib Capsules Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Ceritinib Capsules Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Ceritinib Capsules Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Ceritinib Capsules Sales Value Share by Application (2021-2026) Table 40. Global Ceritinib Capsules Sales Value Share by Application (2027-2032) Table 41. Global Ceritinib Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Ceritinib Capsules Sales by Region (2021-2026) & (K Units) Table 43. Global Ceritinib Capsules Sales Market Share by Region (2021-2026) Table 44. Global Ceritinib Capsules Sales by Region (2027-2032) & (K Units) Table 45. Global Ceritinib Capsules Sales Market Share by Region (2027-2032) Table 46. Global Ceritinib Capsules Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Ceritinib Capsules Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Ceritinib Capsules Sales Value Share by Region (2021-2026) Table 49. Global Ceritinib Capsules Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Ceritinib Capsules Sales Value Share by Region (2027-2032) Table 51. Global Ceritinib Capsules Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Ceritinib Capsules Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Ceritinib Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Ceritinib Capsules Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Ceritinib Capsules Sales by Country (2021-2026) & (K Units) Table 56. Global Ceritinib Capsules Sales Market Share by Country (2021-2026) Table 57. Global Ceritinib Capsules Sales by Country (2027-2032) & (K Units) Table 58. Global Ceritinib Capsules Sales Market Share by Country (2027-2032) Table 59. Global Ceritinib Capsules Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Ceritinib Capsules Sales Value Market Share by Country (2021-2026) Table 61. Global Ceritinib Capsules Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Ceritinib Capsules Sales Value Market Share by Country (2027-2032) Table 63. Novartis Company Information Table 64. Novartis Business Overview Table 65. Novartis Ceritinib Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Novartis Ceritinib Capsules Product Portfolio Table 67. Novartis Recent Development Table 68. Jiangsu Aosaikang Pharmaceutical Company Information Table 69. Jiangsu Aosaikang Pharmaceutical Business Overview Table 70. Jiangsu Aosaikang Pharmaceutical Ceritinib Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Jiangsu Aosaikang Pharmaceutical Ceritinib Capsules Product Portfolio Table 72. Jiangsu Aosaikang Pharmaceutical Recent Development Table 73. Key Raw Materials Table 74. Raw Materials Key Suppliers Table 75. Ceritinib Capsules Distributors List Table 76. Ceritinib Capsules Customers List Table 77. Research Programs/Design for This Report Table 78. Authors List of This Report Table 79. Secondary Sources Table 80. Primary Sources List of Figures Figure 1. Ceritinib Capsules Product Image Figure 2. Global Ceritinib Capsules Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ceritinib Capsules Sales Value (2021-2032) & (US$ Million) Figure 4. Global Ceritinib Capsules Sales (2021-2032) & (K Units) Figure 5. Global Ceritinib Capsules Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Ceritinib Capsules Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 150mg Image Figure 10. 450mg Image Figure 11. Global Ceritinib Capsules Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Ceritinib Capsules Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Ceritinib Capsules Sales Volume Share by Type (2021-2032) Figure 14. Global Ceritinib Capsules Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Ceritinib Capsules Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Ceritinib Capsules Sales Value Share by Type (2021-2032) Figure 17. Locally Advanced NSCLC Image Figure 18. Metastatic NSCLC Image Figure 19. Global Ceritinib Capsules Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Ceritinib Capsules Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Ceritinib Capsules Sales Volume Share by Application (2021-2032) Figure 22. Global Ceritinib Capsules Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Ceritinib Capsules Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Ceritinib Capsules Sales Value Share by Application (2021-2032) Figure 25. Global Ceritinib Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Ceritinib Capsules Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Ceritinib Capsules Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Ceritinib Capsules Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Ceritinib Capsules Sales Value (2021-2032) & (US$ Million) Figure 30. North America Ceritinib Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Ceritinib Capsules Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Ceritinib Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Ceritinib Capsules Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Ceritinib Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Ceritinib Capsules Sales Value (2021-2032) & (US$ Million) Figure 36. South America Ceritinib Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Ceritinib Capsules Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Ceritinib Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Ceritinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Ceritinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Ceritinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Ceritinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Ceritinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Ceritinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Ceritinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Ceritinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Ceritinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Ceritinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Ceritinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Ceritinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Ceritinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Ceritinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Ceritinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Ceritinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Ceritinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Ceritinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Ceritinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Ceritinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Ceritinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Ceritinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Ceritinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Ceritinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Ceritinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Ceritinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Ceritinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Ceritinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Ceritinib Capsules Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Ceritinib Capsules Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • 150mg
  • 450mg
Applications
  • Locally Advanced NSCLC
  • Metastatic NSCLC
Companies covered
  • Novartis
  • Jiangsu Aosaikang Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ceritinib Capsules Sales Value (2021-2032)
  4. 1.2.2 Global Ceritinib Capsules Sales Volume (2021-2032)
  5. 1.2.3 Global Ceritinib Capsules Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Ceritinib Capsules Market Dynamics
  1. 2.1 Ceritinib Capsules Industry Trends
  2. 2.2 Ceritinib Capsules Industry Drivers
  3. 2.3 Ceritinib Capsules Industry Opportunities and Challenges
  4. 2.4 Ceritinib Capsules Industry Restraints
3 Ceritinib Capsules Market by Company
  1. 3.1 Global Ceritinib Capsules Company Revenue Ranking in 2025
  2. 3.2 Global Ceritinib Capsules Revenue by Company (2021-2026)
  3. 3.3 Global Ceritinib Capsules Sales Volume by Company (2021-2026)
  4. 3.4 Global Ceritinib Capsules Average Price by Company (2021-2026)
  5. 3.5 Global Ceritinib Capsules Company Ranking (2024-2026)
  6. 3.6 Global Ceritinib Capsules Company Manufacturing Base and Headquarters
  7. 3.7 Global Ceritinib Capsules Company Product Type and Application
  8. 3.8 Global Ceritinib Capsules Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Ceritinib Capsules Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Ceritinib Capsules Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Ceritinib Capsules Market by Type
  1. 4.1 Ceritinib Capsules Type Introduction
  2. 4.1.1 150mg
  3. 4.1.2 450mg
  4. 4.2 Global Ceritinib Capsules Sales Volume by Type
  5. 4.2.1 Global Ceritinib Capsules Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Ceritinib Capsules Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Ceritinib Capsules Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Ceritinib Capsules Sales Value by Type
  9. 4.3.1 Global Ceritinib Capsules Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Ceritinib Capsules Sales Value by Type (2021-2032)
  11. 4.3.3 Global Ceritinib Capsules Sales Value Share by Type (2021-2032)
5 Ceritinib Capsules Market by Application
  1. 5.1 Ceritinib Capsules Application Introduction
  2. 5.1.1 Locally Advanced NSCLC
  3. 5.1.2 Metastatic NSCLC
  4. 5.2 Global Ceritinib Capsules Sales Volume by Application
  5. 5.2.1 Global Ceritinib Capsules Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Ceritinib Capsules Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Ceritinib Capsules Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Ceritinib Capsules Sales Value by Application
  9. 5.3.1 Global Ceritinib Capsules Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Ceritinib Capsules Sales Value by Application (2021-2032)
  11. 5.3.3 Global Ceritinib Capsules Sales Value Share by Application (2021-2032)
6 Ceritinib Capsules Regional Sales and Value Analysis
  1. 6.1 Global Ceritinib Capsules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ceritinib Capsules Sales by Region (2021-2032)
  3. 6.2.1 Global Ceritinib Capsules Sales by Region: 2021-2026
  4. 6.2.2 Global Ceritinib Capsules Sales by Region (2027-2032)
  5. 6.3 Global Ceritinib Capsules Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Ceritinib Capsules Sales Value by Region (2021-2032)
  7. 6.4.1 Global Ceritinib Capsules Sales Value by Region: 2021-2026
  8. 6.4.2 Global Ceritinib Capsules Sales Value by Region (2027-2032)
  9. 6.5 Global Ceritinib Capsules Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Ceritinib Capsules Sales Value (2021-2032)
  12. 6.6.2 North America Ceritinib Capsules Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Ceritinib Capsules Sales Value (2021-2032)
  15. 6.7.2 Europe Ceritinib Capsules Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Ceritinib Capsules Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Ceritinib Capsules Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Ceritinib Capsules Sales Value (2021-2032)
  21. 6.9.2 South America Ceritinib Capsules Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Ceritinib Capsules Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Ceritinib Capsules Sales Value Share by Country, 2025 VS 2032
7 Ceritinib Capsules Country-level Sales and Value Analysis
  1. 7.1 Global Ceritinib Capsules Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Ceritinib Capsules Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Ceritinib Capsules Sales by Country (2021-2032)
  4. 7.3.1 Global Ceritinib Capsules Sales by Country (2021-2026)
  5. 7.3.2 Global Ceritinib Capsules Sales by Country (2027-2032)
  6. 7.4 Global Ceritinib Capsules Sales Value by Country (2021-2032)
  7. 7.4.1 Global Ceritinib Capsules Sales Value by Country (2021-2026)
  8. 7.4.2 Global Ceritinib Capsules Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Ceritinib Capsules Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Ceritinib Capsules Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Ceritinib Capsules Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Ceritinib Capsules Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Ceritinib Capsules Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Ceritinib Capsules Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Ceritinib Capsules Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Ceritinib Capsules Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Ceritinib Capsules Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Ceritinib Capsules Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Ceritinib Capsules Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Ceritinib Capsules Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Ceritinib Capsules Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Ceritinib Capsules Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Ceritinib Capsules Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Ceritinib Capsules Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Ceritinib Capsules Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Ceritinib Capsules Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Ceritinib Capsules Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Ceritinib Capsules Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Ceritinib Capsules Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Ceritinib Capsules Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Ceritinib Capsules Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Ceritinib Capsules Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Ceritinib Capsules Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Ceritinib Capsules Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Ceritinib Capsules Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Ceritinib Capsules Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Ceritinib Capsules Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Ceritinib Capsules Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis
  2. 8.1.1 Novartis Company Information
  3. 8.1.2 Novartis Business Overview
  4. 8.1.3 Novartis Ceritinib Capsules Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novartis Ceritinib Capsules Product Portfolio
  6. 8.1.5 Novartis Recent Developments
  7. 8.2 Jiangsu Aosaikang Pharmaceutical
  8. 8.2.1 Jiangsu Aosaikang Pharmaceutical Company Information
  9. 8.2.2 Jiangsu Aosaikang Pharmaceutical Business Overview
  10. 8.2.3 Jiangsu Aosaikang Pharmaceutical Ceritinib Capsules Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Jiangsu Aosaikang Pharmaceutical Ceritinib Capsules Product Portfolio
  12. 8.2.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ceritinib Capsules Value Chain Analysis
  2. 9.1.1 Ceritinib Capsules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ceritinib Capsules Sales Mode & Process
  6. 9.2 Ceritinib Capsules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ceritinib Capsules Distributors
  9. 9.2.3 Ceritinib Capsules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst